Usefulness of Screening in Bladder Cancer
The 2nd International Consultation on Bladder Cancer presented recommendations on the screening, diagnosis, and markers of bladder cancer (Kamat et al. in Eur Urol 63(1):4–15, 2013). This demonstrated cystoscopy alone is the most cost-effective method to detect recurrence of bladder cancer (Kamat et al. in Eur Urol 63(1):4–15, 2013). This chapter reviews the usefulness of screening in bladder cancer.
- Clin B, “RecoCancerProf” Working Group, Pairon JC. Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement. BMC Public Health. 2014;14:1155.Google Scholar
- Kamat AM, Hegarty PK, Gee JR, Clark PE, Svatek RS, Hegarty N, Shariat SF, Xylinas E, Schmitz-Dräger BJ, Lotan Y, Jenkins LC, Droller M, van Rhijn BW, Karakiewicz PI. International consultation on urologic disease-European association of urology consultation on bladder cancer 2012. ICUD-EAU international consultation on bladder cancer 2012: screening, diagnosis, and molecular markers. Eur Urol. 2013;63(1):4–15.CrossRefGoogle Scholar